Evidence map›Paper›PMID 42399777›Full record

ArticleBMC genomics2026

Transposable element disruption of a second thyroglobulin-like gene confers Vip3Aa resistance in Helicoverpa armigera.

Andreas Bachler, Tom Kieran Walsh, Dan Andrews, Michelle Williams, Wee Tek Tay, Karl Gordon, Bill James, Cao Fang, Lisi Wang, Yidong Wu and 2 more

Abstract read
In one paragraph

Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andreas BachlerCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia. Andy.Bachler@csiro.au.
Tom Kieran WalshCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia.
Dan AndrewsDivision of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, 2601, Australia.
Michelle WilliamsCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia.
Wee Tek TayCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia.
Karl GordonCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia.
Bill JamesCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia.
Cao FangCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia.
Lisi WangCollege of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, China.
Yidong WuCollege of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, China.
Eric Alan StoneBiological Data Science Institute, Research School of Biology, Australian National University, Canberra, ACT, 2601, Australia.
Amanda PadovanCSIRO, Black Mountain Laboratories, Canberra, ACT, 2601, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe cotton bollworm Helicoverpa armigera is a major global pest controlled by genetically engineered crops expressing Bacillus thuringiensis (Bt) toxins, including Vip3Aa. While Vip3Aa is widely deployed, the genetic basis of resistance remains poorly understood. Previous work identified disruption of a thyroglobulin-like gene (HaVipR1) as one mechanism of resistance, suggesting additional loci may be involved.

resultsUsing linkage analysis, transcriptomics, long-read sequencing, and CRISPR-Cas9 gene editing, we identify a second thyroglobulin-like gene, HaVipR2, as a novel mediator of Vip3Aa resistance. Resistance in a field-derived H. armigera line was shown to be monogenic, recessive, and autosomal, mapping to chromosome 29. Long-read sequencing revealed a ~ 16 kb transposable element insertion disrupting HaVipR2, which was undetectable using standard short-read approaches. CRISPR-Cas9 knockout of HaVipR2 conferred > 900-fold resistance, confirming its causal role. Comparative analyses show that HaVipR1 and HaVipR2 share conserved domain architecture, indicating that thyroglobulin-domain proteins represent a recurrent target of resistance evolution.

conclusionsOur findings establish thyroglobulin-domain proteins as a new class of Bt resistance genes in Lepidoptera and demonstrate that transposable element insertions can drive adaptive resistance while evading detection by conventional methods. These results highlight the importance of long-read sequencing and accurate genome annotation for resistance monitoring and provide new insights into the molecular basis and evolution of Vip3Aa resistance.

Indexed as

Bacterial ProteinsDNA Transposable ElementsHelicoverpa armigeraInsect ProteinsThyroglobulinAnimalsCRISPR-Cas SystemsBacterial ProteinsDNA Transposable ElementsInsect ProteinsThyroglobulinVip3A protein, Bacillus thuringiensisCRISPR-Cas9 knockoutHelicoverpa armigeraTransposable elementsVip3Aa

Identifiers

PMID42399777
PMCPMC13617716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.